Open AccessIdentification of risk factors for carbamazepine-induced serious mucocutaneous adverse reactions: A case-control study using data from spontaneous adverse drug reaction reports
Author(s) -
Ilma Bertulyte,
Sofie Schwan,
Pär Hallberg
Publication year - 2014
Publication title -
journal of pharmacology and pharmacotherapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.301
H-Index - 34
eISSN - 0976-5018
pISSN - 0976-500X
DOI - 10.4103/0976-500x.130051
Subject(s) - medicine , carbamazepine , erythema multiforme , mucocutaneous zone , odds ratio , rash , adverse effect , dermatology , toxic epidermal necrolysis , confidence interval , adverse drug reaction , drug eruption , drug , pharmacovigilance , epilepsy , pharmacology , disease , psychiatry
To identify risk factors other than genetic for severe carbamazepine-induced mucocutaneous reactions, that is, SJS, TEN, and exfoliative dermatitis (ED).